Secondary analyses for empiric prescription and discontinuation times across MALDI vs. VITEK–enterobacteriaceae vs. Non-fermenters^*; appropriateness of therapy changes.

Abstract

Secondary analyses for empiric prescription and discontinuation times across MALDI vs. VITEK–enterobacteriaceae vs. Non-fermenters*; appropriateness of therapy changes.</p